2023
Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
Hanna J, Smolderen K, Castro‐Dominguez Y, Romain G, Lee M, Turner J, Mena‐Hurtado C. Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease. Journal Of The American Heart Association 2023, 12: e028622. PMID: 36974774, PMCID: PMC10122876, DOI: 10.1161/jaha.122.028622.Peer-Reviewed Original ResearchConceptsEarly-stage chronic kidney diseaseChronic kidney diseaseBare metal stentsDrug-eluting stentsDrug-coated balloonsMortality riskAmputation riskKidney diseaseSevere chronic kidney diseaseMajor amputation riskPlain balloon angioplastyDrug-Coated BalloonAmputation outcomesCKD statusAmputation rateCause mortalityBackground PatientsAdjusted analysisBalloon angioplastyFemoropopliteal interventionsDES useBMS useRegistry dataDisease trialsPatients
2011
Real-World Lessons From the Implementation of a Depression Screening Protocol in Acute Myocardial Infarction Patients
Smolderen KG, Buchanan DM, Amin AA, Gosch K, Nugent K, Riggs L, Seavey G, Spertus JA. Real-World Lessons From the Implementation of a Depression Screening Protocol in Acute Myocardial Infarction Patients. Circulation Cardiovascular Quality And Outcomes 2011, 4: 283-292. PMID: 21505152, PMCID: PMC3336360, DOI: 10.1161/circoutcomes.110.960013.Peer-Reviewed Original ResearchConceptsDepression screening protocolAcute myocardial infarction patientsPatient Health QuestionnaireMyocardial infarction patientsScreening protocolInfarction patientsPHQ-9AHA recommendationsAcute Myocardial Infarction RegistryAmerican Heart Association statementMyocardial Infarction RegistryCoronary artery diseaseAcute myocardial infarctionQuality improvement initiativesFull PHQ-9Implementation feedbackAHA statementCoronary patientsArtery diseaseMyocardial infarctionPHQ-2Provider suggestionsHealth QuestionnaireRegistry dataScreening program